Barry A. Bunin

1.8k total citations
26 papers, 1.3k citations indexed

About

Barry A. Bunin is a scholar working on Molecular Biology, Computational Theory and Mathematics and Infectious Diseases. According to data from OpenAlex, Barry A. Bunin has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 19 papers in Computational Theory and Mathematics and 7 papers in Infectious Diseases. Recurrent topics in Barry A. Bunin's work include Computational Drug Discovery Methods (19 papers), Tuberculosis Research and Epidemiology (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Barry A. Bunin is often cited by papers focused on Computational Drug Discovery Methods (19 papers), Tuberculosis Research and Epidemiology (7 papers) and Pharmacogenetics and Drug Metabolism (6 papers). Barry A. Bunin collaborates with scholars based in United States, United Kingdom and South Africa. Barry A. Bunin's co-authors include Jonathan A. Ellman, Sean Ekins, Matthew J. Plunkett, Moses M. Hohman, Joel S. Freundlich, Kelly Chibale, Peter J. Smith, Nadia K. Litterman, Robert C. Reynolds and Christopher A. Lipinski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Barry A. Bunin

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barry A. Bunin United States 17 841 491 439 232 124 26 1.3k
Alfonso T. García‐Sosa Estonia 22 675 0.8× 490 1.0× 287 0.7× 84 0.4× 43 0.3× 54 1.2k
James E. Mills United Kingdom 18 534 0.6× 299 0.6× 235 0.5× 107 0.5× 48 0.4× 36 1.1k
Gopalakrishnan Bulusu India 25 803 1.0× 303 0.6× 339 0.8× 108 0.5× 46 0.4× 62 1.4k
Pierre Bonneau Canada 24 677 0.8× 181 0.4× 394 0.9× 411 1.8× 150 1.2× 39 1.6k
Gergely M. Makara United States 16 599 0.7× 353 0.7× 365 0.8× 60 0.3× 47 0.4× 34 1.1k
Andrea Zaliani Germany 17 1.1k 1.4× 737 1.5× 216 0.5× 185 0.8× 37 0.3× 63 1.8k
Ruth Brenk United Kingdom 27 1.5k 1.8× 659 1.3× 754 1.7× 106 0.5× 59 0.5× 61 2.3k
Juan C. Alvarez United States 11 477 0.6× 317 0.6× 395 0.9× 91 0.4× 56 0.5× 14 1.1k
Konrad Bleicher Switzerland 18 903 1.1× 405 0.8× 388 0.9× 48 0.2× 91 0.7× 38 1.5k
Iris Antes Germany 25 1.1k 1.3× 201 0.4× 327 0.7× 101 0.4× 188 1.5× 67 1.8k

Countries citing papers authored by Barry A. Bunin

Since Specialization
Citations

This map shows the geographic impact of Barry A. Bunin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry A. Bunin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry A. Bunin more than expected).

Fields of papers citing papers by Barry A. Bunin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry A. Bunin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry A. Bunin. The network helps show where Barry A. Bunin may publish in the future.

Co-authorship network of co-authors of Barry A. Bunin

This figure shows the co-authorship network connecting the top 25 collaborators of Barry A. Bunin. A scholar is included among the top collaborators of Barry A. Bunin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry A. Bunin. Barry A. Bunin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clark, Alex M., et al.. (2021). Using Machine Learning to Parse Chemical Mixture Descriptions. ACS Omega. 6(34). 22400–22409. 3 indexed citations
2.
Clark, Alex M., Leah McEwen, Peter Gedeck, & Barry A. Bunin. (2019). Capturing mixture composition: an open machine-readable format for representing mixed substances. Journal of Cheminformatics. 11(1). 33–33. 12 indexed citations
3.
Ekins, Sean, et al.. (2018). Data Mining and Computational Modeling of High-Throughput Screening Datasets. Methods in molecular biology. 1755. 197–221. 9 indexed citations
4.
Clark, Alex M., et al.. (2016). BioAssay Templates for the semantic web. PeerJ Computer Science. 2. e61–e61. 7 indexed citations
5.
Ekins, Sean, et al.. (2016). Collaborative drug discovery for More Medicines for Tuberculosis (MM4TB). Drug Discovery Today. 22(3). 555–565. 8 indexed citations
6.
Ekins, Sean, Nadia K. Litterman, Christopher A. Lipinski, & Barry A. Bunin. (2015). Thermodynamic Proxies to Compensate for Biases in Drug Discovery Methods. Pharmaceutical Research. 33(1). 194–205. 19 indexed citations
7.
Ekins, Sean, Robert C. Reynolds, Scott G. Franzblau, et al.. (2013). Enhancing Hit Identification in Mycobacterium tuberculosis Drug Discovery Using Validated Dual-Event Bayesian Models. PLoS ONE. 8(5). e63240–e63240. 45 indexed citations
8.
Ekins, Sean & Barry A. Bunin. (2013). The Collaborative Drug Discovery (CDD) Database. Methods in molecular biology. 993. 139–154. 20 indexed citations
9.
Ekins, Sean, Robert C. Reynolds, Hiyun Kim, et al.. (2013). Bayesian Models Leveraging Bioactivity and Cytotoxicity Information for Drug Discovery. Chemistry & Biology. 20(3). 370–378. 81 indexed citations
10.
Ekins, Sean, Allen Casey, David M. Roberts, Tanya Parish, & Barry A. Bunin. (2013). Bayesian models for screening and TB Mobile for target inference with Mycobacterium tuberculosis. Tuberculosis. 94(2). 162–169. 30 indexed citations
11.
Sarker, Malabika, Carolyn Talcott, Peter B. Madrid, et al.. (2012). Combining Cheminformatics Methods and Pathway Analysis to Identify Molecules with Whole-Cell Activity Against Mycobacterium Tuberculosis. Pharmaceutical Research. 29(8). 2115–2127. 24 indexed citations
12.
Ekins, Sean, et al.. (2010). A collaborative database and computational models for tuberculosis drug discovery. Molecular BioSystems. 6(5). 840–851. 68 indexed citations
13.
Ekins, Sean, Takushi Kaneko, Christopher A. Lipinski, et al.. (2010). Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis. Molecular BioSystems. 6(11). 2316–2324. 57 indexed citations
14.
Gupta, Rishi R., Eric Gifford, Chris L. Waller, et al.. (2010). Using Open Source Computational Tools for Predicting Human Metabolic Stability and Additional Absorption, Distribution, Metabolism, Excretion, and Toxicity Properties. Drug Metabolism and Disposition. 38(11). 2083–2090. 70 indexed citations
15.
Ekins, Sean, Rishi R. Gupta, Eric Gifford, Barry A. Bunin, & Chris Waller. (2010). Chemical Space: Missing Pieces in Cheminformatics. Pharmaceutical Research. 27(10). 2035–2039. 16 indexed citations
16.
Hohman, Moses M., et al.. (2009). Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery. Drug Discovery Today. 14(5-6). 261–270. 100 indexed citations
17.
Bunin, Barry A.. (2007). Chemoinformatics : theory, practice, & products. Springer eBooks. 10 indexed citations
18.
Bunin, Barry A.. (2003). Increasing the efficiency of small-molecule drug discovery. Drug Discovery Today. 8(18). 823–826. 7 indexed citations
19.
Bunin, Barry A., Matthew J. Plunkett, & Jonathan A. Ellman. (1996). [26] Synthesis and evaluation of 1,4-benzodiazepine libraries. Methods in enzymology on CD-ROM/Methods in enzymology. 267. 448–465. 18 indexed citations
20.
Bunin, Barry A. & Jonathan A. Ellman. (1992). A general and expedient method for the solid-phase synthesis of 1,4-benzodiazepine derivatives. Journal of the American Chemical Society. 114(27). 10997–10998. 340 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026